|
|||||
|
|
||||||
© 2000 American Society for Clinical Oncology
Case 2: Meningeal Relapse in Hodgkins DiseaseArthur Skarin, MDConsultant Editor
Queen Mary Hospital, University of Hong Kong, Hong Kong CASE 2: MENINGEAL RELAPSE IN HODGKINS DISEASE A 23-year-old woman with clinical stage IIA nodular sclerosing Hodgkins disease involving bilateral cervical lymph nodes achieved complete remission (CR) in Canada after mantle-field irradiation (40 Gy). She remained in CR until she developed progressive headache, blurred vision, and mental obtundation. A computed tomography (CT) scan showed a large lobulated mass in the right parieto-occipital region, measuring 7 cm in the greatest dimension. It had a broad base abutting the dura in the right parietal vertex with midline shift (Fig 1A, an unenhanced axial CT scan of the brain, shows a hyperdense slightly lobulated mass with peritumoral edema, while Fig 1B, an enhanced scan, shows homogeneous enhancement of the lesion; note the enhancing dural tail [arrowheads]). Craniotomy showed a meningeal tumor, and complete excision of the tumor was performed. Histologic examination of the excised tumor showed extensive replacement of the meninges by classical Hodgkins disease, which was characterized by the presence of an abnormal lymphoid infiltration with numerous lacunar and Reed-Sternberg cells in a background of mixed reactive inflammatory cells, including eosinophils (Fig 2). She did not have any B symptoms. One month later, she developed a left cervical lymph node. Excisional lymph node biopsy showed recurrent Hodgkins disease. A complete blood count showed a hemoglobin level of 12.8 g/dL (normal range, 11 to 16 g/dL), platelet count of 230 x 109/L (normal range, 150 to 400 x 109/L), and leukocyte count of 8 x 109/L (normal range, 4 to 11 x 109/L) with normal differential. Her serum lactate dehydrogenase level was 260 µL (normal, < 400 µL). Serology results for HIV were negative. A CT scan of the thorax and abdomen, a bipedal lymphangiogram, and a gallium scan did not show disease elsewhere. Bilateral trephine biopsies were negative for disease. She was treated with cranial irradiation (20 Gy) at the site of disease and six courses of cyclophosphamide, vincristine, procarbazine, and prednisolone. She remains in CR with no clinical evidence of neurologic deficit as of August 1999.
Hodgkins disease in the CNS is rare,1-3 with an overall incidence of 0.2% in the published series.4 Of 2,185 patients with Hodgkins disease seen at Stanford University, none had intracranial disease at presentation and only 12 patients (0.5%) later developed documented intracranial disease over a 20-year period.1,2 Most patients with CNS Hodgkins disease present with headache, cranial nerve palsy, motor deficits, and seizures caused by the mass effects. Dural involvement is more common than intracerebral lesions. The majority of the cases are of classical Hodgkins disease, nodular sclerosis type,1-3 which constitutes more than half of the cases.4 Our patient had nodular sclerosing Hodgkins disease and developed meningeal relapse after a remission of 8 years. The main differential diagnosis in our case was a meningioma, based on the CT findings of a hyperdense, extra-axial, dural-based mass, with homogeneous contrast enhancement. Because of the rarity of CNS Hodgkins disease, most published radiologic series have almost exclusively been on CNS non-Hodgkins lymphoma.5-7 The CT appearances for both primary and secondary CNS non-Hodgkins lymphoma are identical; most occur as solitary, homogeneously enhancing lesions in thecentral grey matter/corpus callosum that may encroach on an ependymal or meningeal surface.5,7 Close contact with the meninges may mimic a meningioma.6,7 In our case, two imaging features were atypical of a meningioma: the absence of adjacent skull vault hyperostosis and the presence of marked peritumoral edema.6,7 Our findings suggest that the imaging features of intracranial Hodgkins disease may be comparable to those of non-Hodgkins lymphoma. Histologic examination was, however, essential in our case for definitive diagnosis. The presence of Reed-Sternberg and lacunar cells, together with the history of Hodgkins disease, clinched the final diagnosis of meningeal relapse in Hodgkins disease. Response to therapy is often poor,3,8 with survival reported to range from 6 to 180+ months after intracranial presentation.1,4 However, when combined-modality treatment (neurosurgery if indicated, irradiation and combination chemotherapy) is given with curative intent, prolonged disease-free survival may be achieved.1,4 Indeed, our patient had curative surgical excision of the tumor followed by combination chemotherapy and radiotherapy and remained in CR for 6 years after the intracranial relapse. REFERENCES 1. Sapozink MD, Kaplan HS: Intracranial Hodgkins disease: A report of 12 cases and review of the literature. Cancer 52:1301-1307, 1983[Medline] 2. Burke JS: Hodgkins disease: Histopathology and differential diagnosis, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD,Williams & Wilkins, 1992, pp 497-533 3. Cavalli F: Rare syndromes in Hodgkins disease. Ann Oncol 9:s109-s113, 1998 (Suppl 5)
4.
Anselmo AP, Prioa A, Cartoni C, et al: Meningeal localization in patient with Hodgkins disease: Description of a case and review of the literature. Ann Oncol 7:1071-1075, 1996
5.
Clifford RJ, ONeill BP, Banks PM, et al: Central nervous system lymphoma: Histologic types and CT appearance. Radiology 167:211-215, 1988 6. Herkes GK, Partington MD, ONeill BP: Neurological features of cranial vault lymphomas: A report of two cases. Neurosurgery 29:898-901, 1991[Medline] 7. Gutman J, Kendall B: Unusual appearances of primary central nervous system non-Hodgkins lymphoma. Clin Radiol 49:292-702, 1994 8. Kaplan HS: Patterns of anatomic distribution, in Kaplan HS (ed): Hodgkins Disease (ed 2). Cambridge, MA,Harvard University Press, 1980, pp 280-339
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2000 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|